| Dennis L Ostrem, MD | |
|
3424 Lindi Ct, Carmichael, CA 95608-3969 | |
| (916) 944-7629 | |
| Not Available |
| Full Name | Dennis L Ostrem |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Location | 3424 Lindi Ct, Carmichael, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336227040 | NPI | - | NPPES |
| 00G330520 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | G33052 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dennis L Ostrem, MD 3424 Lindi Ct, Carmichael, CA 95608-3969 Ph: (916) 944-7629 | Dennis L Ostrem, MD 3424 Lindi Ct, Carmichael, CA 95608-3969 Ph: (916) 944-7629 |
News Archive
Halozyme Therapeutics, Inc. today announced the issuance of U.S. Patent No. 7,767,429 claiming its proprietary recombinant human hyaluronidase enzyme platform (rHuPH20). Claims to the human PH20 glycoprotein, PEGylated variants, the glycoprotein produced by recombinant methods, and pharmaceutical compositions with other agents, including antibodies, insulins, cytokines, anti-infectives and additional therapeutic classes were awarded in the '429 patent. Additional claims are in prosecution.
UnitedHealth Group Inc. (UNH), the largest U.S. health insurer by sales, said it will buy XLHealth Corp., a provider of managed care for chronically ill Medicare members, to strengthen a growth area likely to gain increasing support from the U.S. government as it trims costs. The purchase price was about $2 billion, according to a person familiar with the deal who asked not to be identified because the price wasn't disclosed. … The purchase of XLHealth, with 111,000 members, is the seventh since Jan. 1 involving companies that manage Medicare coverage.
Karla Kerlikowske, MD, and team recently published a paper in the Journal of the National Cancer Institute that examined the role of common risk factors in the development of ER-positive and ER-negative breast cancers.
Dutch biopharmaceutical company Crucell N.V. and the Aeras Global TB Vaccine Foundation today announced the start of a Phase II clinical trial in infants of the jointly developed tuberculosis (TB) vaccine candidate, AERAS-402/Crucell Ad35.
It's said that you can judge a man by the quality of his enemies. If the same principle applies to legislation, the Affordable Care Act -; which was signed into law two years ago, but for the most part has yet to take effect -; sits in a place of high honor.
› Verified 5 days ago
Hussam Kujok, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3609 Mission Ave, Suite A, Carmichael, CA 95608 Phone: 916-971-9000 Fax: 916-971-9010 | |
Mr. Harith S Hammoodi Al-shuwaykh, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6501 Coyle Avenue, Carmichael, CA 95608 Phone: 916-537-5079 Fax: 916-966-3189 | |
Dr. Nay Nay Thiri, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6555 Coyle Ave Ste 280, Carmichael, CA 95608 Phone: 916-536-3560 Fax: 916-536-3567 | |
Guillermo Alberto Mantilla, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6555 Coyle Ave Ste 280, Carmichael, CA 95608 Phone: 916-536-3540 Fax: 916-536-3541 | |
Mei Qiang, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6501 Coyle Ave, Carmichael, CA 95608 Phone: 916-537-5079 | |
Syama S. Varudu, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6501 Coyle Ave, Hospitalist Program, Carmichael, CA 95608 Phone: 916-537-5079 Fax: 916-966-3189 |